As a world leading cancer care company they aim to improve the health and quality of life for every person with cancer - today, now, when it counts. Their vision is to help people with cancer get the most of every day. As one of the world's leading cancer care companies, their goal is to make everything they do, from the products they choose to license to the quality standards they apply to manufacturing, count towards improving the lives of people with cancer.

Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ.

Helsinn Birex Pharmaceuticals Ltd. develops and manufactures oral dosage drug products. It is engaged in providing oral solid dosage forms and topical forms of pharmaceutical products and packaging of sterile products. The firm supplies its partners with ready to sell products on an exclusive basis, which are manufactured on site and using a network of external manufacturing partners. The company was founded by Gabriele Braglia on May 18, 1978 and is headquartered in Dublin, Ireland.

Part of Helsinn Healthcare SA, Helsinn Advanced Synthesis SA is a company headquartered in Biasca, Switzerland, that develops and manufactures pharmaceutical ingredients.

Samyang Biopharmaceuticals Corp. wholesales medical supplies and other medicine-related products. The company was founded on November 1, 2011 and is headquartered in Seongnam, South Korea.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Manufactures and develops pharmaceutical products

Hisamitsu Pharmaceutical Co., Ltd, a subsidiary of Hisamitsu Pharmaceutical Co., Inc., is a Taiwanese company located in Taipei. The firm manufactures and markets pharmaceuticals.

YOOYOUNG PHARMACEUTICAL is finished pharmaceutical product manufacturer highly dedicated to the CMO (Contrast Manufacturing Organization) of oral solid and sterile dosage form in full compliance with GMP since its foundation in 1981. Services include separated automatic production line for Cephalosporin vial injection and capsule as well as ampoule and pre-filled syringe filling in aseptic conditions and a variety form of oral dosage, customized packing and tailor-made custom manufacturing for customers’ needs in cost-effective way. YOOYOUNG focuses on the development and innovation of generic product for global market and already has many years of experience of contract manufacturing with over 15 countries including Japan, Russia, HongKong, Thailand. They guarantee the best service to you ever.

Luxena Pharmaceuticals, Inc. is an American private company. The firm develops and manufactures pharmaceutical formulation.

Roche Palo Alto, engages in the discovery, development, and marketing of medicines for inflammatory or viral diseases. The company provides medicines for the treatment for a range of diseases, including severe asthma, chronic obstructive pulmonary disease, and rheumatoid arthritis. The company was formerly known as Syntex (U.S.A.) LLC and changed its name in 1994. The company was incorporated in 1960 and is based in Palo Alto, California. Roche Palo Alto, LLC operates as a subsidiary of Roche Holding AG. Source (businessweek) {http://investing.businessweek.com.libproxy1.nus.edu.sg/research/stocks/private/snapshot.asp?privcapId=8102245}

Hangzhou Jiuyuan Gene Engineering develops and sells biochemical and chemical pharmaceuticals and other medical equipment. Their products include filgrastim, oprelvekin, enoxaparin sodium, palonosetron, and recombinant human bone morphogenetic protein. Their drug pipeline mainly includes liraglutide, fulvestrant, fosaprepitant, and pegfilgrastim.

Perrigo API Ltd. develops and markets active pharmaceutical ingredients. The company was founded in 1987 and is headquartered in Bnei Brak, Israel.

Shenzhen Wanle Pharmaceutical Co., Ltd., established on 1990-07-04, Business scope includes general business items:,The licensing program is:to develop,Research,Production and operation of raw materials,small volume injection(Contains anti-tumor),Freeze-dried powder injection(Contains anti-tumor),tablet,Capsules(contain anti-tumor),Imported medicines are packaged separately(tablet),Accessories(Polyethylene glycol monomethyl ether-polylactic acid block copolymer),Goods and technology import and export business.

Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (doing business as Chia Tai-Tianqing Pharmaceutical Co Ltd) is a company headquartered in Lianyungang, China. The firm manufactures pharmaceutical products. It was founded in 1969. Kang Xin Yu is the current CEO of the firm.

Chongqing Pharmaceutical Research Institute Co., Ltd., a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., is a Chinese company located in Chongqing. The firm manufactures pharmaceutical products.

Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. Its operations are carried out through the following segments: Medical related, Pharmaceutical related, Pharma Packaging, and Others. The Medical related segment provides injection and infusion-related products, artificial organ-related products, functional products, and dialysis and diabetes-related products. The Pharmaceutical related segment involves the manufacture and sale of injections, oral agents, and pharmaceutical kit products. The Pharma Packaging segment provides glass products for bottle tubes, ampoules, thermos-use, and lighting. The Others segment includes real estate leasing. The company was founded on July 8, 1954 and is headquartered in Osaka, Japan.

Glenmark Generics Ltd., part of Glenmark Pharmaceuticals Ltd., is a company headquartered in Mumbai, India. The firm manufactures and markets generic drugs.

Hangzhou Haida Pharmaceutical Chemical Co., Ltd., established on 2002-10-25, Business scope includes technology development,Technical Services,Achievement transfer:Fine Chemicals,Pharmaceutical Intermediates,animal and plant extracts,natural cosmetics,Healthy food,Environmentally friendly catering packaging,precision machinery,experiment equipment;wholesale,retail:Electronic chemical products,Instrumentation;Import and export of goods or technology(law,Except for items prohibited by administrative regulations,law,Projects that are restricted by administrative regulations can only be operated after obtaining a license);Including the business scope of subordinate branches(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

LP Pharmaceuticals (Xiamen) Co., Ltd., located in Xiamen Biomedical Industry Base which formulates and manufactures pharmaceuticals with enhanced delivery properties. The company was founded in 2012 by a group of scientists and business professionals with extensive experience in the US and Chinese pharmaceutical industry. Proprietary delivery platforms include mucosal and oral controlled release. Therapeutic areas currently concern central nervous system, digestive system, cardiovascular, cancer and AIDS.